Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82001-82050 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05525481
Tamoxifen Prediction Study in Patients With ER+ Breast Cancer
PHASE4Recruiting
100 participants
Started: Nov 1, 2022 · Completed: Feb 28, 2024
1 condition1 sponsor1 location
NCT05671497
The Effect of Cilostazol on Rheumatoid Arthritis Patients
PHASE2/PHASE3Active, not recruiting
70 participants
Started: Nov 1, 2022 · Completed: Oct 1, 2024
1 condition3 sponsors1 location
NCT06287177
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
N/ARecruiting
1,000 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2024
1 condition1 sponsor1 location
NCT06159179
Medical Thoracoscopy for Undiagnosed Transudative and Exudative Pleural Effusion
NARecruiting
124 participants
Started: Nov 1, 2022 · Completed: May 15, 2024
1 condition2 sponsors1 location
NCT05585801
Continuous Glucose Monitoring in Intensive Care Unit
NARecruiting
500 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06325917
Effect of Diabetes Self-management Education and Support on Glycemic Control Among Patients With Type 2 Diabetic
NAActive, not recruiting
140 participants
Started: Nov 1, 2022 · Completed: Jul 30, 2024
1 condition1 sponsor1 location
NCT05863039
Resistance Training With Blood Flow Restriction
NAActive, not recruiting
60 participants
Started: Nov 1, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05609188
Black Economic Equity Movement
NAActive, not recruiting
300 participants
Started: Nov 1, 2022 · Completed: Jul 30, 2025
4 conditions4 sponsors1 location
NCT05742880
Effect of Face Masks on Pulmonary Function in Patients With COPD
NARecruiting
40 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05567796
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
PHASE3Active, not recruiting
3,400 participants
Started: Nov 1, 2022 · Completed: Oct 19, 2026
1 condition1 sponsor230 locations
NCT05604976
Single Catheter Primary Percutaneous Coronary Intervention Method in Patients With ST Elevation Myocardial Infarction
NAEnrolling by invitation
430 participants
Started: Nov 1, 2022 · Completed: Dec 20, 2025
1 condition2 sponsors1 location
NCT05582499
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
PHASE2Recruiting
716 participants
Started: Nov 1, 2022 · Completed: Sep 30, 2028
10 conditions1 sponsor1 location
NCT05611112
Problem-Solving Therapy for Patients With Chronic Disease and Poor Mental Well-being in General Practice
NAActive, not recruiting
188 participants
Started: Nov 1, 2022 · Completed: Mar 1, 2025
3 conditions5 sponsors1 location
NCT03870360
Preventing Anxiety and Depression in Older Hispanics
NAActive, not recruiting
240 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT05539482
Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents
NARecruiting
1,200 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05817396
Dissemination of Physical Activity-related Health Competence in Vocational Education of Nursing Care
NAActive, not recruiting
640 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2025
5 conditions3 sponsors1 location
NCT05540613
Tai Chi Versus Conventional Exercise to Improve Cognitive Performance in Older Adults With Mild Cognitive Impairment
NARecruiting
315 participants
Started: Nov 1, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05628805
Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome
EARLY_PHASE1Recruiting
30 participants
Started: Nov 1, 2022 · Completed: Feb 16, 2026
4 conditions2 sponsors1 location
NCT05694000
Hippocampus DBS in Treatment-resistant Schizophrenia
NARecruiting
6 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05568654
Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
NARecruiting
12,500 participants
Started: Nov 1, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor12 locations
NCT05620706
Study of GPC-3 CAR-T Cells in Treating With Hepatocellular Carcinoma
NARecruiting
20 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT05476809
Upgraded Smart Cloth Home Care System for Persons With Dementia
NARecruiting
60 participants
Started: Nov 1, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor2 locations
NCT04616729
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
PHASE1/PHASE2Recruiting
30 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06520761
The Effect of Injectable PRF Vs LLL on Orthodontic Tooth Movement
NAActive, not recruiting
20 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2024
2 conditions1 sponsor1 location
NCT05669092
A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status
PHASE3Recruiting
174 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05543785
Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries
NARecruiting
76 participants
Started: Nov 1, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05314946
Nutritional Support During Induction Therapy for Esophageal Cancer
NARecruiting
26 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05678101
TENS for Relief of Postoperative Pain in Orthopedic Patients
NAActive, not recruiting
30 participants
Started: Nov 1, 2022 · Completed: Dec 30, 2025
5 conditions1 sponsor1 location
NCT05922540
a Cohort Study of Ischemic Cerebrovascular Disease
N/ARecruiting
5,000 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT05785780
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NARecruiting
30 participants
Started: Nov 1, 2022 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06043921
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
N/ARecruiting
150 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06336174
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
N/ARecruiting
100 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06023056
Hepatitis B Vaccination After Neonatal Surgery
N/ARecruiting
180 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2030
5 conditions1 sponsor1 location
NCT05496582
The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma
N/ARecruiting
100 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT05445804
Oral Cannabidiol for Tobacco Cessation
PHASE1Recruiting
50 participants
Started: Nov 1, 2022 · Completed: Feb 1, 2026
5 conditions2 sponsors1 location
NCT04117997
Validation Fugl-Meyer in Italian Language (FMI)
N/ARecruiting
70 participants
Started: Nov 1, 2022 · Completed: Dec 1, 2025
1 condition2 sponsors1 location
NCT05655754
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
PHASE4Recruiting
100 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05052086
Magnetomotoric Ultrasound (MMUS) in Rectal Cancer
NARecruiting
60 participants
Started: Nov 1, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05305287
Quantifying Hepatic Mitochondrial Fluxes in Humans
PHASE4Recruiting
60 participants
Started: Nov 1, 2022 · Completed: Mar 31, 2027
3 conditions2 sponsors2 locations
NCT05558631
Longitudinal Study of Health Literacy in the Municipality of Leiria
N/ANot yet recruiting
4,003 participants
Started: Nov 1, 2022 · Completed: Jan 31, 2033
1 condition1 sponsor0 locations
NCT05254184
KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC
PHASE1Recruiting
12 participants
Started: Nov 1, 2022 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT05728216
Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings for the Diagnosis of Either Acute Kidney Injury or Chronic Kidney Disease in Routine Practices (NEPHROCT)
N/ARecruiting
50 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
3 conditions2 sponsors1 location
NCT05844813
Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
PHASE4Enrolling by invitation
102 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2027
1 condition7 sponsors6 locations
NCT05387603
Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
PHASE3Recruiting
300 participants
Started: Nov 1, 2022 · Completed: Oct 1, 2026
1 condition1 sponsor4 locations
NCT05404581
Insula Neuromodulation for Chronic Neuropathic Pain
NARecruiting
12 participants
Started: Nov 1, 2022 · Completed: Jun 29, 2027
2 conditions2 sponsors1 location
NCT05606263
Efficacy and Safety of Caldonirimab Plus Nimotuzumab for Recurrent or Metastatic Cervical Cancer
PHASE2Recruiting
55 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05846763
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study
N/ARecruiting
50 participants
Started: Nov 1, 2022 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT05734365
COPD-ICU Multicentre Prospective Observational Register
N/ARecruiting
500 participants
Started: Nov 1, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06529562
Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
NARecruiting
384 participants
Started: Nov 1, 2022 · Completed: Nov 1, 2032
1 condition8 sponsors1 location
NCT05601232
A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA
PHASE2Active, not recruiting
10 participants
Started: Nov 1, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors1 location